NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

exwannabe,

There was probably only a very narrow window of time when DCVax-Prostrate would have had some serious attention from anyone. Big pharma didn't like the business model chances for success let alone limited benefit seen to begin with. Then when Provenge was approved up until DNDN bankruptcy the challenges became obvious even if better management could have made it profitable to a limited extent. During this time frame DCVax-L might have had some interest shown simply because they had a better process in place to control cost of goods sold. The main problem for NWBO would have been they never had enough money in the coffers to partner with good terms so the study would have been nearly completely in the hands of a partner if there was an offer of some sort actually made. That offer, if ever made, may have included rights to additional indications for the base DCVax technology as well. Too much guessing here, I know, but that is generally how it works with a cash strapped company.